From the FDA Drug Label
The FDA drug label does not answer the question.
From the Research
Monjaro is not a recognized medication or substance in the provided evidence, and therefore, its effects on weight loss cannot be determined. However, based on the most recent and highest quality study available 1, medications that mimic the action of hormones such as GLP-1 and GIP, like tirzepatide, have been shown to cause significant weight loss by slowing stomach emptying, increasing feelings of fullness, reducing hunger signals in the brain, and improving insulin sensitivity. Some key points to consider when evaluating weight loss medications include:
- The medication should be used in combination with lifestyle interventions, such as a healthy diet and regular physical activity.
- The choice of medication should be based on the individual patient's needs and medical history.
- The most effective medications for weight loss, such as semaglutide and tirzepatide, have been associated with significant weight loss, with average losses of 11.4% and 12.4% of body weight, respectively, compared to placebo 1.
- Common side effects of weight loss medications include nausea, diarrhea, and constipation, which often improve over time.
- The medication works gradually, with most weight loss occurring over several months of consistent use. It is essential to consult with a healthcare professional to determine the best course of treatment for weight loss, as they can help evaluate the potential benefits and risks of different medications and develop a personalized plan for achieving and maintaining a healthy weight.